Navigation Links
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite Study
Date:1/26/2012

visit http://www.auxilium.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This release contains "forward-looking-statements" within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the potential for XIAFLEX to treat edematous fibrosclerotic panniculopathy, commonly known as cellulite; the timing of release of topline results from the phase Ib study of XIAFLEX for the treatment of cellulite; the number of people with cellulite and the market opportunity represented by that number ; and products in development for Peyronie's disease, Frozen Shoulder syndrome and cellulite; and all other statements containing projections, statements of future performance or expectations, our beliefs or statements of plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Forward-looking statements can generally be identified by words such as "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and other words and terms of similar meaning in connection with any discussion of projections, future performance or expectations, beliefs, plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, decisions by regulatory authorities as to whether and when to approve drug applications, and general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in Auxilium's Annual Report under the heading "Risk Factors" on Form 10-K for the year ended December 31, 2010 and the Company's
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 LifeScienceIndustryResearch.com ... Research Report on Global and China Lysine Industry ... a professional and the deep research report in ... Lysine basic information including definition, classification specifications, application, ... US, Europe , ...
(Date:4/17/2015)... 17, 2015 CVS Health Corporation (NYSE: ... Friday, May 1, 2015, at 8:30 a.m. (EDT) with ... results. An audio webcast of the conference ... portion of the CVS Health website for all interested ... This webcast will be archived and available on the ...
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., ... announced today that clinical data presented at the ... its urine-based Precision Cancer Monitoring ℠ (PCM) ... monitoring of EGFR T790M mutations in ... Detection of EGFR T790M Mutation in Urinary Circulating ...
Breaking Medicine Technology:Lysine Market International (US, Europe, Japan) Research Analysis 2Lysine Market International (US, Europe, Japan) Research Analysis 3Lysine Market International (US, Europe, Japan) Research Analysis 4Lysine Market International (US, Europe, Japan) Research Analysis 5Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... 2011 Visionary Pharmaceuticals, Inc., announced today that ... a consortium of Angel Investors. The company is ... retinoic acid related orphan receptor (ROR) modulators targeting ... disorders including rheumatoid arthritis, multiple sclerosis, psoriasis and ...
... Ind., July 26, 2011 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... for the period ending July 2, 2011 before the market ... an accompanying conference call at 8:00 a.m. ET on Thursday, ...
Cached Medicine Technology:Visionary Pharmaceuticals, Inc., Announces Initial Seed Round Investments and the Launch of TH17 Autoimmune Disease Research Activities 2Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:4/17/2015)... April 17, 2015 Alcohol and Violence ... (NCADD) notes that drinking and driving has been the ... the same time, the link between alcohol and crime ... abuse and violence and sexual assault, and their relationship ... the NCADD, 5.3 million adults in America were drinking ...
(Date:4/17/2015)... From the day Dr. Todd Phillips founded The ... has empowered young people to create meaningful change in their ... water and the Gospel to all of Liberia by 2020 ... and 27, students, faculty and staff raised $21,000 through the ... and the Good News of Jesus. , During the ...
(Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed ... HR 1849 in congress on April 16, 2015 in ... patients with the genetic disease. , The bill, ... the first to create a federally led and financed ... hemorrhagic telangiectasia. This would effectively prevent premature death and ...
(Date:4/17/2015)... At the end of February 2015, Choices Recovery ... the Oscars” in the Stardust Penthouse on the rooftop ... Los Angeles skyline. These events honoring the 2015 Oscar ... producer of sustainable product placement in TV and film. ... of eco-friendly and socially conscious products and services, the ...
(Date:4/17/2015)... Baptist Health and The University of Texas ... designed to transform oncology care in northeast Florida and ... create a joint cancer program to enhance patient access ... MD Anderson Cancer Center is anticipated to open in ... highly coordinated, multidisciplinary cancer care for adults in the ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3
... with first product sales since 2005, SEATTLE, May ... reported financial results for the quarter ended,March 31, 2008. ... $20,000 for the first quarter of 2007. Gross product ... first quarter of 2008., Total operating expenses increased ...
... Holdings, Inc. ("Holdings",or the "Company"), the parent company ... nation,s largest cancer services companies, reported revenue of,$810.6 ... cash flow of,$50.9 million for the quarter ended ... include those of US Oncology, its wholly-owned,subsidiary, through ...
... CorVel Corporation,(Nasdaq: CRVL ) announced today that Gordon ... Bank of America 2008 Health Care Services,Conference on Tuesday, ... be,held at the Four Seasons Hotel in Las Vegas, ... through a webcast on,CorVel,s website, http://www.corvel.com . To ...
... result of San Diego State,University,s interim suspension ... supports the decisions of our,member fraternities to ... parties accountable for their actions. The NIC, ... with our member organizations and San,Diego State ...
... Inter-Con Security Officers Report They Don,t Have Healthcare, ... OAKLAND, Calif., May 7 In the ... increasing,number of security officers report they either don,t ... their families., Kaiser contractor Inter-Con Security is ...
... ALEXANDRIA, Va., May 7 The American Physical,Therapy ... coalition of,health and consumer groups to advocate for ... Safety of Seniors Act., In remarks during ... and National Falls Free Coalition representative Bonita,Lynn Beattie, ...
Cached Medicine News:Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 2Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 3Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 4Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 5Health News:Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results 6Health News:US Oncology Reports First Quarter 2008 Results 2Health News:US Oncology Reports First Quarter 2008 Results 3Health News:US Oncology Reports First Quarter 2008 Results 4Health News:US Oncology Reports First Quarter 2008 Results 5Health News:US Oncology Reports First Quarter 2008 Results 6Health News:US Oncology Reports First Quarter 2008 Results 7Health News:US Oncology Reports First Quarter 2008 Results 8Health News:US Oncology Reports First Quarter 2008 Results 9Health News:US Oncology Reports First Quarter 2008 Results 10Health News:US Oncology Reports First Quarter 2008 Results 11Health News:US Oncology Reports First Quarter 2008 Results 12Health News:US Oncology Reports First Quarter 2008 Results 13Health News:US Oncology Reports First Quarter 2008 Results 14Health News:US Oncology Reports First Quarter 2008 Results 15Health News:US Oncology Reports First Quarter 2008 Results 16Health News:US Oncology Reports First Quarter 2008 Results 17Health News:CorVel Announces Appearance at Bank of America Health Care Conference 2Health News:Workers With No Healthcare Protecting Kaiser Facilities, Security Contractor May Be Misleading California's Largest Healthcare Provider 2Health News:Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 2
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 27G x 7/8in (.40 x 22mm), angled 10mm from end....
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 27G x 7/8 in (.40 x 22mm)....
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)...
... (Electronystagmography) is a complete vestibular diagnostic ... eye movements collected via electrodes. Its ... to use. Saccade, tracking and Slow ... interpretation is facilitated by graphic comparison ...
Medicine Products: